Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Electronic Medical Records Speed Genetic Research

By LabMedica International staff writers
Posted on 10 May 2011
A new study revealed that mining data from electronic medical records (EMRs) is a faster way to get insights into disease processes.

Recruiting thousands of patients to collect health data for genetic clues to disease is expensive and time consuming. More...
However, process of collecting data for genetic studies could be faster and cheaper by instead mining patient data that already exists in electronic medical records, according to new research.

In the study, researchers were able to cull patient information in EMRs from routine physicians' visits at five US sites that all used different brands of medical record software. The information allowed researchers to identify accurately patients with five kinds of diseases or health disorders--type 2 diabetes, dementia, peripheral arterial disease, cataracts, and cardiac conduction.

"The hard part of doing genetic studies has been identifying enough people to get meaningful results," said lead investigator Abel Kho, MD, an assistant professor of medicine at Northwestern University Feinberg School of Medicine (Chicago, IL, USA) and a physician at Northwestern Memorial Hospital. "Now we've shown you can do it using data that's already been collected in electronic medical records and can rapidly generate large groups of patients."

The study's findings were published April 20, 2011, in the journal Science Translational Medicine. To identify the diseases, Dr. Kho and colleagues searched the records using a series of criteria such as medications, diagnoses, and laboratory tests. They then tested their results against the gold standard-- review by physicians. The physicians validated the results, according to Dr. Kho. The electronic health records allowed researchers to identify patients' diseases with 73% to 98% accuracy.

The researchers also were able to reproduce previous genetic findings from prospective studies using the EMRs. The five institutions that participated in the study collected genetic samples for research. Patients agreed to the use of their records for studies.

Sequencing individuals' genomes is becoming faster and less expensive. It soon may be possible to include patients' genomes in their medical records, Dr. Kho noted. This would create a plentiful resource for genetic research. "With permission from patients, you could search electronic health records at not just five sites but 25 or 100 different sites and identify 10,000 or 100,000 patients with diabetes, for example," Dr. Kho said.

The larger the group of patients for genetic studies, the better the ability to detect rarer affects of the genes and the more detailed genetic sequences that cause a person to develop a disease. The study also revealed across-the-board weaknesses in institutions' electronic medical records. The institutions didn't do a good job of capturing race and ethnicity, smoking status, and family history, all which are important areas of study, Dr. Kho reported. "It shows we need to focus our efforts to use electronic medical records more meaningfully," he added.

The institutions participating in the study are part of a consortium called the Electronic Medical Records and Genomics Network (eMERGE). The research was supported by the US National Human Genome Research Institute with additional funding from the US National Institute of General Medical Sciences, both based in Bethesda, MD, USA.

Related Links:

Northwestern University Feinberg School of Medicine



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.